Dirk Wohlleber
Overview
Explore the profile of Dirk Wohlleber including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
1763
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Harbauer A, Schneider A, Wohlleber D
Annu Rev Anal Chem (Palo Alto Calif)
. 2022 Mar;
15(1):1-16.
PMID: 35303775
Cellular organelles are highly specialized compartments with distinct functions. With the increasing resolution of detection methods, it is becoming clearer that same organelles may have different functions or properties not...
12.
Knolle P, Huang L, Kosinska A, Wohlleber D, Protzer U
Vaccines (Basel)
. 2021 Nov;
9(11).
PMID: 34835264
Chronic hepatitis B affects more than 250 million individuals worldwide, putting them at risk of developing liver cirrhosis and liver cancer. While antiviral immune responses are key to eliminating hepatitis...
13.
Manske K, Schneider A, Ko C, Knolle P, Steiger K, Protzer U, et al.
Viruses
. 2021 Nov;
13(11).
PMID: 34835079
Immunity against hepatitis B virus (HBV) infection is complex and not entirely understood so far, including the decisive factors leading to the development of chronic hepatitis B. This lack of...
14.
Laudenbach B, Krey K, Emslander Q, Andersen L, Reim A, Scaturro P, et al.
Nat Commun
. 2021 Nov;
12(1):6918.
PMID: 34824277
While viral replication processes are largely understood, comparably little is known on cellular mechanisms degrading viral RNA. Some viral RNAs bear a 5'-triphosphate (PPP-) group that impairs degradation by the...
15.
Fischer A, Manske K, Seissler J, Wohlleber D, Simm N, Wolf-van Buerck L, et al.
Xenotransplantation
. 2020 Aug;
27(6):e12634.
PMID: 32808410
Background: Ubiquitous expression of T-cell regulatory transgenes such as the cytotoxic T lymphocyte-associated antigen 4 (CTLA4) or the high-affinity variant LEA29Y improves xeno graft survival. Such donor pigs are however...
16.
Schober S, Thiede M, Gassmann H, Prexler C, Xue B, Schirmer D, et al.
Cells
. 2020 Jul;
9(7).
PMID: 32610710
In this study we report the functional comparison of T cell receptor (TCR)-engineered major histocompatibility complex (MHC) class I-restricted CD4 versus CD8 T cells targeting a peptide from (STEAP1) in...
17.
Lampl S, Janas M, Donakonda S, Brugger M, Lohr K, Schneider A, et al.
J Hepatol
. 2020 Jun;
73(6):1347-1359.
PMID: 32598967
Background & Aims: Selective elimination of virus-infected hepatocytes occurs through virus-specific CD8 T cells recognizing peptide-loaded MHC molecules. Herein, we report that virus-infected hepatocytes are also selectively eliminated through a...
18.
Laschinger M, Wang Y, Holzmann G, Wang B, Stoss C, Lu M, et al.
FASEB J
. 2020 Apr;
34(6):8125-8138.
PMID: 32329113
The effectiveness of liver regeneration limits surgical therapies of hepatic disorders and determines patient outcome. Here, we investigated the role of the neuropeptide calcitonin gene-related peptide (CGRP) for liver regeneration...
19.
Schulte R, Wohlleber D, Unrau L, Geers B, Metzger C, Erhardt A, et al.
Int J Mol Sci
. 2020 Apr;
21(7).
PMID: 32260486
The nuclear receptor peroxisome proliferator-activated receptor gamma (PPARγ) regulates target gene expression upon ligand binding. Apart from its effects on metabolism, PPARγ activity can inhibit the production of pro-inflammatory cytokines...
20.
Namineni S, OConnor T, Faure-Dupuy S, Johansen P, Riedl T, Liu K, et al.
J Hepatol
. 2020 Jan;
72(5):960-975.
PMID: 31954207
Background & Aims: Hepatic innate immune control of viral infections has largely been attributed to Kupffer cells, the liver-resident macrophages. However, hepatocytes, the parenchymal cells of the liver, also possess...